Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics
- PMID: 28972303
- DOI: 10.1111/pcmr.12650
Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics
Abstract
Metastatic uveal melanoma (UM) is invariably fatal, usually within a year of diagnosis. There are currently no effective therapies, and clinical studies employing kinase inhibitors have so far demonstrated limited success. This is despite common activating mutations in GNAQ/11 genes, which trigger signalling pathways that might predispose tumours to a variety of targeted drugs. In this study, we have profiled kinome expression network dynamics in various human ocular melanomas. We uncovered a shared transcriptional profile in human primary UM samples and across a variety of experimental cell-based models. The poor overall response of UM cells to FDA-approved kinase inhibitors contrasted with much higher sensitivity to the bromodomain inhibitor JQ1, a broad transcriptional repressor. Mechanistically, we identified a repressed FOXM1-dependent kinase subnetwork in JQ1-exposed cells that contained multiple cell cycle-regulated protein kinases. Consistently, we demonstrated vulnerability of UM cells to inhibitors of mitotic protein kinases within this network, including the investigational PLK1 inhibitor BI6727. We conclude that analysis of kinome-wide signalling network dynamics has the potential to reveal actionable drug targets and inhibitors of potential therapeutic benefit for UM patients.
Keywords: BI6727; JQ1; PLK1; kinase inhibitor; kinome; transcriptomics; uveal melanoma.
© 2017 The Authors. Pigment Cell & Melanoma Research Published by John Wiley & Sons.
Similar articles
-
BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.Oncotarget. 2015 Oct 20;6(32):33397-409. doi: 10.18632/oncotarget.5179. Oncotarget. 2015. PMID: 26397223 Free PMC article.
-
Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma.Mol Cancer. 2019 Sep 16;18(1):140. doi: 10.1186/s12943-019-1070-7. Mol Cancer. 2019. PMID: 31526394 Free PMC article.
-
Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086. Epub 2012 May 1. Clin Cancer Res. 2012. PMID: 22550165 Free PMC article.
-
Treatment of Uveal Melanoma.Cancer Treat Res. 2016;167:281-93. doi: 10.1007/978-3-319-22539-5_12. Cancer Treat Res. 2016. PMID: 26601868 Review.
-
Oncogenic signaling in uveal melanoma.Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672. doi: 10.1111/pcmr.12708. Epub 2018 May 23. Pigment Cell Melanoma Res. 2018. PMID: 29738114 Review.
Cited by
-
The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.Cell Oncol (Dordr). 2022 Aug;45(4):601-619. doi: 10.1007/s13402-022-00686-5. Epub 2022 Jul 4. Cell Oncol (Dordr). 2022. PMID: 35781872 Free PMC article.
-
Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives.Cancers (Basel). 2019 Jun 18;11(6):846. doi: 10.3390/cancers11060846. Cancers (Basel). 2019. PMID: 31216772 Free PMC article. Review.
-
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.Sci Signal. 2018 Sep 25;11(549):eaat7951. doi: 10.1126/scisignal.aat7951. Sci Signal. 2018. PMID: 30254057 Free PMC article.
-
High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma.Cell Rep Med. 2023 Nov 21;4(11):101244. doi: 10.1016/j.xcrm.2023.101244. Epub 2023 Oct 18. Cell Rep Med. 2023. PMID: 37858338 Free PMC article.
-
Uveal melanoma: progress in molecular biology and therapeutics.Ther Adv Med Oncol. 2020 Oct 22;12:1758835920965852. doi: 10.1177/1758835920965852. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33149769 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
